Effect of pembrolizumab (pembro) on hepatitis B viral (HBV) load and aminotransferase (ALT) levels in patients (pts) with advanced hepatocellular carcinoma (aHCC) in KEYNOTE-224 and KEYNOTE-240.

Stephen L. Chan,Andrew X. Zhu,Richard S. Finn,Julien Edeline,Sadahisa Ogasawara,Jennifer J. Knox,Bruno Daniele,Baek-Yeol Ryoo,Philippe Merle,Mohamed Bouattour,Ho Yeong Lim,Yee Chao,Thomas Yau,Barbara A. Haber,Usha Malhotra,Chih-Chin Liu,Masatoshi Kudo,Ann-Lii Cheng

Effect of pembrolizumab (pembro) on hepatitis B viral (HBV) load and aminotransferase (ALT) levels in patients (pts) with advanced hepatocellular carcinoma (aHCC) in KEYNOTE-224 and KEYNOTE-240.

2020

Stephen L. Chan
Andrew X. Zhu
Richard S. Finn
Julien Edeline
Sadahisa Ogasawara
Jennifer J. Knox
Bruno Daniele
Baek-Yeol Ryoo
Philippe Merle
Mohamed Bouattour
Ho Yeong Lim
Yee Chao
Thomas Yau
Barbara A. Haber
Usha Malhotra
Chih-Chin Liu
Masatoshi Kudo
Ann-Lii Cheng

4587Background: The effect of PD-1 inhibition on HBV infection is unclear, and pts with HBV are often excluded from trials. This analysis evaluated HBV viral load and liver function (ALT levels) in...

Keywords:

Internal medicine
Gastroenterology
Pembrolizumab
Medicine
Hepatocellular carcinoma
Hepatitis b viral
in patient
Pathology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations